A citation-based method for searching scientific literature

Domenica Lorusso, Antonio González-Martín, Isabelle Ray-Coquard. Future Oncol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.
Yusuke Yamamoto, Gang Ning, Brooke E Howitt, Karishma Mehra, Lingyan Wu, Xia Wang, Yue Hong, Florian Kern, Tay Seok Wei, Ting Zhang,[...]. J Pathol 2016
41
100

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
Damian Szklarczyk, Annika L Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, Nadezhda T Doncheva, John H Morris, Peer Bork,[...]. Nucleic Acids Res 2019
100

Therapy resistance mediated by cancer stem cells.
Teresa Bernadette Steinbichler, József Dudás, Sergej Skvortsov, Ute Ganswindt, Herbert Riechelmann, Ira-Ida Skvortsova. Semin Cancer Biol 2018
98
100

Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation.
Pia Sommerkamp, Nina Cabezas-Wallscheid, Andreas Trumpp. Trends Mol Med 2021
5
100

Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
Juan Liu, Zongjian Tan, Jun He, Tingting Jin, Yuanyuan Han, Li Hu, Jukun Song, Shengwen Huang. Biosci Rep 2020
2
100

A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer.
Qinchuan Wang, Xiyong Liu, Chen Chen, Jida Chen, Beisi Xu, Lini Chen, Jichun Zhou, Yasheng Huang, Wenjun Chen, Rongyue Teng,[...]. Transl Oncol 2021
2
100

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, Aaron Bell, Michael E Johnson, Kwong-kwok Wong, Dong-Choon Park, Ke Hao, Daniel K P Yip, Howard Donninger,[...]. Cancer Cell 2009
157
100


Cancer cells stemness: A doorstep to targeted therapy.
Sahdeo Prasad, Sharavan Ramachandran, Nehal Gupta, Itishree Kaushik, Sanjay K Srivastava. Biochim Biophys Acta Mol Basis Dis 2020
36
100


A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
Diane D Mao, Amit D Gujar, Tatenda Mahlokozera, Ishita Chen, Yanchun Pan, Jingqin Luo, Taylor Brost, Elizabeth A Thompson, Alice Turski, Eric C Leuthardt,[...]. Cell Rep 2015
58
100



Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
Kun-Hao Bai, Si-Yuan He, Ling-Ling Shu, Wei-Da Wang, Shi-Yong Lin, Qian-Yi Zhang, Liang Li, Lei Cheng, Yu-Jun Dai. Cancer Med 2020
20
100

Systematic pan-cancer analysis of tumour purity.
Dvir Aran, Marina Sirota, Atul J Butte. Nat Commun 2015
455
100

Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
Chiara Mignogna, Nicoletta Staropoli, Cirino Botta, Carmela De Marco, Antonia Rizzuto, Michele Morelli, Annalisa Di Cello, Renato Franco, Caterina Camastra, Ivan Presta,[...]. J Ovarian Res 2016
30
100

Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype.
Xue Hao, Bo Zhao, Wei Zhou, Heng Liu, Takeshi Fukumoto, Dmitry Gabrilovich, Rugang Zhang. iScience 2020
3
100

Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
Fei Wu, Yun Lin, Peng Cui, Hongyun Li, Lechao Zhang, Zeqiang Sun, Shengliang Huang, Shun Li, Shiming Huang, Qingli Zhao,[...]. Cancer Chemother Pharmacol 2018
12
100

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer.
Madhuri Koti, Robert J Gooding, Paulo Nuin, Alexandria Haslehurst, Colleen Crane, Johanne Weberpals, Timothy Childs, Peter Bryson, Moyez Dharsee, Kenneth Evans,[...]. BMC Cancer 2013
74
100

A novel strategy to block mitotic progression for targeted therapy.
Junlong Jack Chi, Hongchun Li, Zhuan Zhou, Javier Izquierdo-Ferrer, Yifan Xue, Cindy M Wavelet, Gary E Schiltz, Bin Zhang, Massimo Cristofanilli, Xinghua Lu,[...]. EBioMedicine 2019
16
100

NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer.
Timothy Nacarelli, Takeshi Fukumoto, Joseph A Zundell, Nail Fatkhutdinov, Stephanie Jean, Mark G Cadungog, Mark E Borowsky, Rugang Zhang. Cancer Res 2020
21
100

E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential.
Yuanqi Liu, Chaojun Duan, Chunfang Zhang. Front Pharmacol 2021
3
100

Aurora kinases in ovarian cancer.
J Alejandro Pérez-Fidalgo, Valentina Gambardella, Begoña Pineda, Octavio Burgues, Oscar Piñero, Andrés Cervantes. ESMO Open 2020
2
100

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Haoya Xu, Ruoyao Zou, Feifei Li, Jiyu Liu, Nannan Luan, Shengke Wang, Liancheng Zhu. Cancer Med 2021
3
100

Ovarian cancer stem cells and targeted therapy.
Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad, Mohammad Reza Abbaszadegan. J Ovarian Res 2019
21
100

Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.
Taryne Chong, Amila Sarac, Cindy Q Yao, Linda Liao, Nicola Lyttle, Paul C Boutros, John M S Bartlett, Melanie Spears. J Ovarian Res 2018
15
100

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma.
Jian-Hua Wang, Shu-Ting Huang, Lan Zhang, Zi-Gang Liu, Rong-Xin Liang, Sen-Wei Jiang, Yi-Nan Jiang, Xing-Juan Yu, Yu-Chuan Jiang, Xi-Zhao Li,[...]. Cancer Med 2019
14
100

Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists.
Sofia Amante, Filipa Santos, Teresa Margarida Cunha. Insights Imaging 2021
3
100

Histone Modifying Enzymes in Gynaecological Cancers.
Priya Ramarao-Milne, Olga Kondrashova, Sinead Barry, John D Hooper, Jason S Lee, Nicola Waddell. Cancers (Basel) 2021
3
100

Targeting Cancer Stemness in the Clinic: From Hype to Hope.
Caner Saygin, Daniela Matei, Ravindra Majeti, Ofer Reizes, Justin D Lathia. Cell Stem Cell 2019
177
100

Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.
Johanne I Weberpals, Trevor J Pugh, Paola Marco-Casanova, Glenwood D Goss, Natalie Andrews Wright, Prisni Rath, Jonathon Torchia, Alexander Fortuna, Gemma N Jones, Martine P Roudier,[...]. Cancer Med 2021
2
100

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
100

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin.
Nisha Bansal, Douglas C Marchion, Elona Bicaku, Yin Xiong, Ning Chen, Xiaomang B Stickles, Entidhar Al Sawah, Robert M Wenham, Sachin M Apte, Jesus Gonzalez-Bosquet,[...]. J Gynecol Oncol 2012
19
100

The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.
Tamsin Wesley, Stuart Berzins, George Kannourakis, Nuzhat Ahmed. Cell Commun Signal 2021
4
100

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.
Renata A Tassi, Angela Gambino, Laura Ardighieri, Eliana Bignotti, Paola Todeschini, Chiara Romani, Laura Zanotti, Mattia Bugatti, Fulvio Borella, Dionyssios Katsaros,[...]. Br J Cancer 2019
11
100

Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML).
Rima Hajjo, Dima A Sabbah, Sanaa K Bardaweel, Alexander Tropsha. Diagnostics (Basel) 2021
1
100

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
Tathiane M Malta, Artem Sokolov, Andrew J Gentles, Tomasz Burzykowski, Laila Poisson, John N Weinstein, Bożena Kamińska, Joerg Huelsken, Larsson Omberg, Olivier Gevaert,[...]. Cell 2018
397
100

7
100

c-MYC and Epithelial Ovarian Cancer.
Jeyshka M Reyes-González, Pablo E Vivas-Mejía. Front Oncol 2021
3
100

Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents.
Giorgia Simonetti, Carla Boga, Joseph Durante, Gabriele Micheletti, Dario Telese, Paolo Caruana, Andrea Ghelli Luserna di Rorà, Fabio Mantellini, Samantha Bruno, Giovanni Martinelli,[...]. Molecules 2021
1
100

Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
Maria A Papadaki, Giannis Stoupis, Panayiotis A Theodoropoulos, Dimitris Mavroudis, Vassilis Georgoulias, Sofia Agelaki. Mol Cancer Ther 2019
69
100

Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers.
Adel Alblihy, Muslim L Alabdullah, Reem Ali, Mashael Algethami, Michael S Toss, Nigel P Mongan, Emad A Rakha, Srinivasan Madhusudan. Biomedicines 2021
2
100


Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.
Mohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, Derek Radisky, Minzhi Zhang, Mark Schroeder, Ann Tuma, Eduard Leof, Jodi M Carter, Amy C Degnim,[...]. Oncogene 2021
6
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.